Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Nov;8(5):585–590. doi: 10.1128/aac.8.5.585

Treatment of Respiratory Klebsiella pneumoniae Infection in Mice with Aerosols of Kanamycin

R F Berendt a, G G Long a,1, J S Walker a
PMCID: PMC429426  PMID: 1108778

Abstract

Aerosols of kanamycin resulted in greater survival of mice challenged with respiratory Klebsiella pneumoniae than the same dosage given intramuscularly. Determinations of viable bacteria in the blood and lungs revealed that aerosolized kanamycin was most effective when infection was confined to the lungs. After the organisms had spread to other areas, however, aerosol therapy was still more effective than intramuscular therapy, but only one-half the infected mice survived.

Full text

PDF
585

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bilodeau M., Roy J. C., Giroux M. Studies of absorption of kanamycin by aerosolization. Ann N Y Acad Sci. 1966 Jun 14;132(2):870–878. doi: 10.1111/j.1749-6632.1966.tb43007.x. [DOI] [PubMed] [Google Scholar]
  2. Graybill J. R., Marshall L. W., Charache P., Wallace C. K., Melvin V. B. Nosocomial pneumonia. A continuing major problem. Am Rev Respir Dis. 1973 Nov;108(5):1130–1140. doi: 10.1164/arrd.1973.108.5.1130. [DOI] [PubMed] [Google Scholar]
  3. HENDERSON D. W. An apparatus for the study of airborne infection. J Hyg (Lond) 1952 Mar;50(1):53–68. doi: 10.1017/s0022172400019422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. MALLIGO J. E., IDOINE L. S. SINGLE-STAGE IMPACTION DEVICE FOR PARTICLE SIZING BIOLOGICAL AEROSOLS. Appl Microbiol. 1964 Jan;12:32–36. doi: 10.1128/am.12.1.32-36.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. McGowan J. E., Jr, Finland M. Infection and antibiotic usage at Boston City Hospital: changes in prevalence during the decade 1964-1973. J Infect Dis. 1974 Apr;129(4):421–428. doi: 10.1093/infdis/129.4.421. [DOI] [PubMed] [Google Scholar]
  6. Miller W. F. Aerosol therapy in acute and chronic respiratory disease. Arch Intern Med. 1973 Jan;131(1):148–155. [PubMed] [Google Scholar]
  7. Prokhorova I. I. Sravnitel'noe izuchenie éffektivnosti ingaliatsionnogo i podkozhnogo metodov vvedeniia kanamitsina pri lechenii i profilaktike éksperimental'noi pneuvmonii belykh myshei. Antibiotiki. 1968 Jun;13(6):529–533. [PubMed] [Google Scholar]
  8. Rose H. D., Heckman M. G., Unger J. D. Pseudomonas aeruginosa pneumonia in adults. Am Rev Respir Dis. 1973 Mar;107(3):416–422. doi: 10.1164/arrd.1973.107.3.416. [DOI] [PubMed] [Google Scholar]
  9. Teske R. H., Miller S. B. Pulmonary absorption and retention of kanamycin after repeated inhalation administration of kanamycin aerosol. Appl Microbiol. 1970 Apr;19(4):583–585. doi: 10.1128/am.19.4.583-585.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tillotson J. R., Finland M. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis. 1969 Jun;119(6):597–624. doi: 10.1093/infdis/119.6.597. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES